BSP Pharmaceuticals S.p.A. is glad to announce its participation to the next 5th Edition of the Highly Potent Active Pharmaceutical Ingedients Summit from 2 to 4 October 2019 in Rome, Italy.
The Highly Potent Active Pharmaceutical Ingredients Summit is organized by VonlantheN Group.
This event provides its participants access to other industry leaders and an environment to discuss process innovation and technology and safety perspectives for both highly potent active pharmaceutical ingredient (HPAPI) manufacturers and outsourcers. This Summit will focus on current market trends for HPAPIs, including process development and scale-up, cost-effective production, containment innovations and best manufacturing practices as well as regulatory updates.
The key topics of the Summit are:
Save the Date!!! During the Conference Day 2 (Thursday 2nd of October), at the 12.35 AM for the Sponsored Speaking Slot, Fabio Zenobi (EHS & Toxicology Director) and Marina Martinelli (EHS Coordinator) will presents the speech ‘Manufacturing of Oncological Products by a CDMO.
To request a meeting, You can send an e-mail at email@example.com